Title:
AZEPINE FUSED RING COMPOUND AS RIPK1 INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/046361
Kind Code:
A1
Abstract:
The present disclosure provides a compound of formula (I), a pharmaceutical composition thereof, and a use thereof in treating and/or preventing diseases or conditions related to the activity of RIPK1 kinase.
Inventors:
NIU DEQIANG (CN)
ZHU ZHENDONG (CN)
YE YIBIN (CN)
ZHANG QING (CN)
HE YONGPING (CN)
WANG YONGJIE (CN)
ZHU ZHENDONG (CN)
YE YIBIN (CN)
ZHANG QING (CN)
HE YONGPING (CN)
WANG YONGJIE (CN)
Application Number:
PCT/CN2023/115773
Publication Date:
March 07, 2024
Filing Date:
August 30, 2023
Export Citation:
Assignee:
ARTIVILA BIOPHARMA (CN)
International Classes:
C07D267/14; A61K31/16; A61P1/00; A61P7/00; A61P17/00; A61P25/00; A61P27/02; A61P29/00; A61P35/00; C07D401/06; C07D401/14; C07D403/06; C07D405/06; C07D495/04; C07D498/04; C07D513/04
Domestic Patent References:
| WO2021228173A1 | 2021-11-18 |
Foreign References:
| CN115246796A | 2022-10-28 | |||
| CN1740173A | 2006-03-01 | |||
| CN110698460A | 2020-01-17 |
Other References:
DATABASE REGISTRY 26 June 2023 (2023-06-26), ANONYMOUS : "Ethanediamide, N1-met hyl-N1-(2-phenyleth yl)-N2-[(3R)-2,3,4,5-t etrahydro-5- methyl-7-[2-(1-meth yl-1H-pyrazol-4-yl)et hynyl]-4-oxo-1,5-ben zothiazepin-3- yl]- (CA INDEX NAME)", XP093144887, retrieved from STN Database accession no. 2936678-71-4
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW CO., LTD. (CN)
Download PDF: